Santos HA - Search Results

1

A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma.

Imlimthan S, Khng YC, Keinänen O, Zhang W, Airaksinen AJ, Kostiainen MA, Zeglis BM, Santos HA, Sarparanta M. Imlimthan S, et al. Among authors: santos ha. Small. 2021 May;17(18):e2007705. doi: 10.1002/smll.202007705. Epub 2021 Mar 18. Small. 2021. PMID: 33738957 Free PMC article.

2

Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.

Bimbo LM, Sarparanta M, Santos HA, Airaksinen AJ, Mäkilä E, Laaksonen T, Peltonen L, Lehto VP, Hirvonen J, Salonen J. Bimbo LM, et al. Among authors: santos ha. ACS Nano. 2010 Jun 22;4(6):3023-32. doi: 10.1021/nn901657w. ACS Nano. 2010. PMID: 20509673 Free article.

3

Multifunctional porous silicon for therapeutic drug delivery and imaging.

Santos HA, Bimbo LM, Lehto VP, Airaksinen AJ, Salonen J, Hirvonen J. Santos HA, et al. Curr Drug Discov Technol. 2011 Sep;8(3):228-49. doi: 10.2174/157016311796799053. Curr Drug Discov Technol. 2011. PMID: 21291407 Review.

4

¹⁸F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography.

Sarparanta M, Mäkilä E, Heikkilä T, Salonen J, Kukk E, Lehto VP, Santos HA, Hirvonen J, Airaksinen AJ. Sarparanta M, et al. Among authors: santos ha. Mol Pharm. 2011 Oct 3;8(5):1799-806. doi: 10.1021/mp2001654. Epub 2011 Sep 7. Mol Pharm. 2011. PMID: 21875120

5

Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.

Sarparanta M, Bimbo LM, Rytkönen J, Mäkilä E, Laaksonen TJ, Laaksonen P, Nyman M, Salonen J, Linder MB, Hirvonen J, Santos HA, Airaksinen AJ. Sarparanta M, et al. Among authors: santos ha. Mol Pharm. 2012 Mar 5;9(3):654-63. doi: 10.1021/mp200611d. Epub 2012 Feb 1. Mol Pharm. 2012. PMID: 22277076

6

The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.

Sarparanta MP, Bimbo LM, Mäkilä EM, Salonen JJ, Laaksonen PH, Helariutta AM, Linder MB, Hirvonen JT, Laaksonen TJ, Santos HA, Airaksinen AJ. Sarparanta MP, et al. Among authors: santos ha. Biomaterials. 2012 Apr;33(11):3353-62. doi: 10.1016/j.biomaterials.2012.01.029. Epub 2012 Jan 29. Biomaterials. 2012. PMID: 22285465

7

Evaluation of the physicochemical and biopharmaceutical properties of fluoro-indomethacin.

Mori MM, Airaksinen AJ, Hirvonen JT, Santos HA, Caramella CM. Mori MM, et al. Among authors: santos ha. Curr Drug Metab. 2013 Jan;14(1):80-9. Curr Drug Metab. 2013. PMID: 22497567

8

Cellular interactions of surface modified nanoporous silicon particles.

Bimbo LM, Sarparanta M, Mäkilä E, Laaksonen T, Laaksonen P, Salonen J, Linder MB, Hirvonen J, Airaksinen AJ, Santos HA. Bimbo LM, et al. Among authors: santos ha. Nanoscale. 2012 May 21;4(10):3184-92. doi: 10.1039/c2nr30397c. Epub 2012 Apr 16. Nanoscale. 2012. PMID: 22508528

9

Amine modification of thermally carbonized porous silicon with silane coupling chemistry.

Mäkilä E, Bimbo LM, Kaasalainen M, Herranz B, Airaksinen AJ, Heinonen M, Kukk E, Hirvonen J, Santos HA, Salonen J. Mäkilä E, et al. Among authors: santos ha. Langmuir. 2012 Oct 2;28(39):14045-54. doi: 10.1021/la303091k. Epub 2012 Sep 20. Langmuir. 2012. PMID: 22967052

10

Nanostructured porous Si-based nanoparticles for targeted drug delivery.

Shahbazi MA, Herranz B, Santos HA. Shahbazi MA, et al. Among authors: santos ha. Biomatter. 2012 Oct-Dec;2(4):296-312. doi: 10.4161/biom.22347. Biomatter. 2012. PMID: 23507894 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters